Physician profile
Bakytbubu Arynova
NPI 1124467253
$1,842.75
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $51.83 · 2021: $345 · 2022: $544 · 2023: $32.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $798.06 | 2019 | |
| Abbvie INC. | $255.21 | 2019-2022 | |
| Organon LLC | $175.80 | 2021-2022 | |
| Aspira Women'S Health INC | $135.49 | 2022 | |
| Coopersurgical, INC. | $76.64 | 2019-2022 | |
| Hologic Sales and Service, LLC | $64.16 | 2020-2023 | Aptima |
| Avion Pharmaceuticals | $61.75 | 2020-2022 | |
| Agile Therapeutics, INC. | $61.29 | 2021 | |
| Exeltis, USA INC. | $43.20 | 2021-2022 | |
| Therapeuticsmd, INC. | $42.57 | 2021 | |
| Ferring Pharmaceuticals INC. | $30.39 | 2019 | |
| Scynexis, INC. | $29.40 | 2022 | |
| Hologic INC | $19.63 | 2021 | |
| Merck Sharp & Dohme LLC | $17.13 | 2021 | |
| Minerva Surgical, INC | $16.55 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $15.48 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bakytbubu Arynova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.